WEREWOLF THERAPEUTICS, INC. Investing Cash Flow
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Investing Cash Flow of $416.00 thousand for the 6-month period ending 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-09-22
- WEREWOLF THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
- WEREWOLF THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- WEREWOLF THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was $0.00.
- WEREWOLF THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was $0.00.
- WEREWOLF THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$769.00K.
- WEREWOLF THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$3.61M.
- WEREWOLF THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2021 was -$498.00K.
- WEREWOLF THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2020 was -$560.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $416.00K S-4 · filed 2026-09-22 | |||
| 2025-12-31 | $0.00 derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | $0.00 derived: sum of 2 quarters · filed 2026-09-22 | $0.00 derived: sum of 3 quarters · filed 2026-09-22 | $0.00 S-4 · filed 2026-09-22 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − S-4 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-09-22 | $0.00 10-Q · filed 2025-11-04 | -$123.00K derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-06-30 | $0.00 derived: S-4 6 month − 10-Q 3 month · filed 2026-09-22 | $0.00 S-4 · filed 2026-09-22 | -$123.00K derived: sum of 3 quarters · filed 2026-09-22 | -$126.00K derived: sum of 4 quarters · filed 2026-09-22 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | -$123.00K derived: sum of 2 quarters · filed 2026-09-22 | -$126.00K derived: sum of 3 quarters · filed 2026-09-22 | -$143.00K derived: sum of 4 quarters · filed 2026-09-22 |
| 2024-12-31 | -$123.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | -$126.00K derived: sum of 2 quarters · filed 2026-09-22 | -$143.00K derived: sum of 3 quarters · filed 2026-09-22 | -$254.00K S-4 · filed 2026-09-22 |
| 2024-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$20.00K derived: sum of 2 quarters · filed 2025-11-04 | -$131.00K 10-Q · filed 2025-11-04 | -$329.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$128.00K 10-Q · filed 2025-08-14 | -$326.00K derived: sum of 3 quarters · filed 2025-08-14 | -$547.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$111.00K 10-Q · filed 2025-05-08 | -$309.00K derived: sum of 2 quarters · filed 2025-05-08 | -$530.00K derived: sum of 3 quarters · filed 2025-05-08 | -$712.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$419.00K derived: sum of 2 quarters · filed 2025-03-11 | -$601.00K derived: sum of 3 quarters · filed 2025-03-11 | -$769.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | -$221.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$403.00K derived: sum of 2 quarters · filed 2024-11-07 | -$571.00K 10-Q · filed 2024-11-07 | -$1.09M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$182.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$350.00K 10-Q · filed 2024-08-08 | -$868.00K derived: sum of 3 quarters · filed 2024-08-08 | -$2.82M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$168.00K 10-Q · filed 2024-05-03 | -$686.00K derived: sum of 2 quarters · filed 2024-05-03 | -$2.64M derived: sum of 3 quarters · filed 2024-05-03 | -$3.75M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$518.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$2.47M derived: sum of 2 quarters · filed 2024-03-07 | -$3.58M derived: sum of 3 quarters · filed 2024-03-07 | -$3.61M 10-K · filed 2024-03-07 |
| 2022-09-30 | -$1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$3.06M derived: sum of 2 quarters · filed 2023-11-14 | -$3.09M 10-Q · filed 2023-11-14 | -$3.37M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.14M 10-Q · filed 2023-08-10 | -$1.41M derived: sum of 3 quarters · filed 2023-08-10 | -$1.51M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$28.00K 10-Q · filed 2023-05-11 | -$300.00K derived: sum of 2 quarters · filed 2023-05-11 | -$402.00K derived: sum of 3 quarters · filed 2023-05-11 | -$513.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$374.00K derived: sum of 2 quarters · filed 2023-03-23 | -$485.00K derived: sum of 3 quarters · filed 2023-03-23 | -$498.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | -$102.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$213.00K derived: sum of 2 quarters · filed 2022-11-10 | -$226.00K 10-Q · filed 2022-11-10 | -$235.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$124.00K 10-Q · filed 2022-08-11 | -$133.00K derived: sum of 3 quarters · filed 2022-08-11 | -$190.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$13.00K 10-Q · filed 2022-05-10 | -$22.00K derived: sum of 2 quarters · filed 2022-05-10 | -$79.00K derived: sum of 3 quarters · filed 2022-05-10 | -$124.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$66.00K derived: sum of 2 quarters · filed 2022-03-24 | -$111.00K derived: sum of 3 quarters · filed 2022-03-24 | -$560.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$102.00K derived: sum of 2 quarters · filed 2021-11-10 | -$551.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$494.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$449.00K 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |